Similarly, genistein (5, 10, 20 μM) treatment significantly decreased MAPK signaling by decreasing the expression of MEK5, ERK5, and p-ERK5 in MDA-MB-231 BC cells [153]. This evidence concerns the gene MAPK7 and breast cancer.